Ark Biotech

Cambridge, United States

Intelligent bioprocess platform

$8.2M raised

May 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ark Biotech raised?

Ark Biotech has raised $8.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.

Who are Ark Biotech's investors?

Ark Biotech's investors include Primary Venture Partners, HCVC, Rob Hayes, Kevin Carter, Natalie Portman.

Where is Ark Biotech headquartered?

Ark Biotech is headquartered in Cambridge, United States.

What does Ark Biotech do?

Intelligent bioprocess platform

What stage is Ark Biotech at?

Ark Biotech is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 24, 2024.

MLA

"Ark Biotech — Funding & Investors." VCBacked, May 24, 2024, https://www.vcbacked.co/company/ark-biotech. Accessed July 4, 2026.

APA

VCBacked. (2024). Ark Biotech — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/ark-biotech

Wikipedia (cite web)

{{cite web |title=Ark Biotech — Funding & Investors |url=https://www.vcbacked.co/company/ark-biotech |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 24, 2024.